Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus
- PMID: 8388509
- PMCID: PMC237692
- DOI: 10.1128/JVI.67.6.3461-3469.1993
Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus
Abstract
Responses of cytotoxic T-cells (Tc) to human cytomegalovirus (CMV) represent the predominant mechanism by which hosts resist CMV infection. The CMV major immediate-early protein (IE) is present throughout the virus replicative cycle. Studies were performed to determine whether Tc specific for IE effectively lyse CMV-infected targets and are thus capable of providing protective immunity against infection. After in vitro stimulation of peripheral blood mononuclear cells with CMV-infected autologous fibroblasts, Tc specific for IE were not readily detectable in CMV-reactive polyclonal Tc lines. However, after stimulation of peripheral blood mononuclear cells with cells selectively expressing IE, weak but detectable IE-specific Tc responses were observed. The frequency of IE-specific Tc clones derived from cultures stimulated with IE-expressing cells was 50 to 100 times lower than the frequency of Tc clones specific for other CMV proteins isolated from cultures stimulated with CMV-infected cells. All of the IE-specific Tc clones, which efficiently lysed targets selectively expressing IE, demonstrated minimal lysis of CMV-infected fibroblasts, despite abundant IE expression in these target cells. In contrast to these results with IE, other viral proteins were efficiently presented during all phases of CMV infection. These data suggest that CMV has evolved a unique mechanism for selectively limiting the presentation of the potentially immunogenic IE protein, which may preclude IE-specific Tc from providing protective immunity to CMV infection.
Similar articles
-
Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.Biol Blood Marrow Transplant. 2001;7(5):247-56. doi: 10.1053/bbmt.2001.v7.pm11400946. Biol Blood Marrow Transplant. 2001. PMID: 11400946
-
Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.J Immunol. 2001 May 1;166(9):5695-703. doi: 10.4049/jimmunol.166.9.5695. J Immunol. 2001. PMID: 11313411
-
Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes.Clin Exp Immunol. 1985 Jul;61(1):80-9. Clin Exp Immunol. 1985. PMID: 2994924 Free PMC article.
-
Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes.J Med Virol. 1994 May;43(1):103-10. doi: 10.1002/jmv.1890430119. J Med Virol. 1994. PMID: 8083644
-
[Immune reaction to human cytomegalovirus].Nihon Rinsho. 1998 Jan;56(1):62-8. Nihon Rinsho. 1998. PMID: 9465666 Review. Japanese.
Cited by
-
Tumors and Cytomegalovirus: An Intimate Interplay.Viruses. 2022 Apr 14;14(4):812. doi: 10.3390/v14040812. Viruses. 2022. PMID: 35458542 Free PMC article. Review.
-
The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation.Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6904-9. doi: 10.1073/pnas.94.13.6904. Proc Natl Acad Sci U S A. 1997. PMID: 9192664 Free PMC article.
-
Uses of flow cytometry in virology.Clin Microbiol Rev. 1994 Oct;7(4):576-604. doi: 10.1128/CMR.7.4.576. Clin Microbiol Rev. 1994. PMID: 7530594 Free PMC article. Review.
-
Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion.PLoS Pathog. 2013;9(5):e1003383. doi: 10.1371/journal.ppat.1003383. Epub 2013 May 23. PLoS Pathog. 2013. PMID: 23717207 Free PMC article. Clinical Trial.
-
Herpesvirus-bacteria synergistic interaction in periodontitis.Periodontol 2000. 2020 Feb;82(1):42-64. doi: 10.1111/prd.12311. Periodontol 2000. 2020. PMID: 31850623 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources